Summary
Latest filing:
Mark R. Defazio is President and CEO of Metropolitan Bank Holding Corp. (MCB). 3 SEC Form 4 filings on record, most recently on 31 March 2026.
Recent Transactions
6Every recent SEC Form 4 transaction Mark R. Defazio has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark R. Defazio files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert C. Patent - $3.70M of MCB open-market activity in the last 12 months
- Nick Rosenberg - $384K of MCB open-market activity in the last 12 months
- Scott Lublin - $372K of MCB open-market activity in the last 12 months
- Harvey Gutman - $269K of MCB open-market activity in the last 12 months
- Daniel F. Dougherty - $242K of MCB open-market activity in the last 12 months
- Anthony J. Fabiano - $10K of MCB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Mark R. Defazio?
Mark R. Defazio is a corporate insider, tracked as President and CEO of Metropolitan Bank Holding Corp. (MCB). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mark R. Defazio last file a Form 4?
The most recent primary Form 4 on record is dated 31 March 2026, one of 3 filings going back to 2026.
Where can I see all of Mark R. Defazio's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Mark R. Defazio and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial